Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM Jackson, C., Choi, J., Zhang, J., Piotrowski, A., Walbert, T., Desai, A., Ahluwalia, M., Nabors, B., Ye, X., Desideri, S., Fisher, J., Wen, P., Grossman, S., Smith, K., Pardoll, D., Lim, M. OXFORD UNIV PRESS INC. 2019: 122
View details for Web of Science ID 000509478702175